| Followers | 48 |
| Posts | 23862 |
| Boards Moderated | 0 |
| Alias Born | 09/16/2012 |
Saturday, January 07, 2023 12:27:54 PM
LOL. Legacy shareholders Big Boy pants must come with Depends for this one.
They've been at this for thirty years! Another example of legacy common losing everything as management walks with millions. Enough of Going it alone! The way to do it (for common shareholders that is) is to partner on each disease for cash up front, then use the proceeds for the next trial. STOP diluting common and doing reverse splits. Get the treatment to the patients.
They've been at this for thirty years! Another example of legacy common losing everything as management walks with millions. Enough of Going it alone! The way to do it (for common shareholders that is) is to partner on each disease for cash up front, then use the proceeds for the next trial. STOP diluting common and doing reverse splits. Get the treatment to the patients.
Recent GERN News
- Geron to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference • GlobeNewswire Inc. • 06/01/2026 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/27/2026 08:01:30 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/26/2026 11:45:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/26/2026 11:45:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/26/2026 11:45:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/26/2026 11:45:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/26/2026 11:45:05 PM
- Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 05/18/2026 08:01:00 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 05/15/2026 12:40:51 PM
- First Real-World Evidence Study of RYTELO® (imetelstat) in Lower-risk Myelodysplastic Syndromes (LR-MDS) to be Presented at EHA 2026 • GlobeNewswire Inc. • 05/12/2026 01:31:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/06/2026 08:49:33 PM
- Geron Corporation Reports First Quarter 2026 Financial Results and Recent Business Highlights • GlobeNewswire Inc. • 05/06/2026 11:00:00 AM
- Geron Plans to Present at Upcoming Investor Conferences • GlobeNewswire Inc. • 05/05/2026 12:00:00 PM
- Geron Plans to Announce First Quarter 2026 Financial Results on May 6, 2026 • GlobeNewswire Inc. • 04/22/2026 11:00:00 AM
- Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 04/20/2026 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/15/2026 12:14:14 AM
- Geron Corporation Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 04/14/2026 08:05:00 PM
- Geron Announces Appointment of Timothy Williams as Executive Vice President, Chief Legal Officer and Corporate Secretary • GlobeNewswire Inc. • 04/13/2026 12:00:00 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/07/2026 08:31:07 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/07/2026 08:30:34 PM
- Geron to Participate in the 25th Annual Needham Virtual Healthcare Conference • GlobeNewswire Inc. • 04/06/2026 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/01/2026 08:30:20 PM
